RUcore: Rutgers University Community Repository
Organizational strategy development for the pharmaceutical industry
Descriptive
TypeOfResource
Text
TitleInfo
(ID = T-1)
Title
Organizational strategy development for the pharmaceutical industry
SubTitle
event structure analysis, comparative boolean analysis, and analogical reasoning model
PartName
PartNumber
NonSort
Identifier
ETD_2349
Identifier
(type = hdl)
http://hdl.rutgers.edu/1782.2/rucore10002600001.ETD.000052188
Language
(objectPart = )
LanguageTerm
(authority = ISO639-2);
(type = code)
eng
Genre
(authority = marcgt)
theses
Subject
(ID = SBJ-1);
(authority = RUETD)
Topic
Global Affairs
Subject
(ID = SBJ-2);
(authority = ETD-LCSH)
Topic
Pharmaceutical policy
Subject
(ID = SBJ-3);
(authority = ETD-LCSH)
Topic
Pharmaceutical industry--Public relations
Subject
(ID = SBJ-4);
(authority = ETD-LCSH)
Topic
Strategic planning
Abstract
This dissertation aims to develop a new direction, in stakeholder management terms, for the pharmaceutical industry to deal with its risks/challenges, particularly in relation to the access to essential, life-saving medicines, posed by its various stakeholders. The organizational strategy development framework of this dissertation is comprised of five phases. The first phase investigates the implications of the stakeholder management perspective for the organizational strategy development in terms of the pharmaceutical industry, examining the concepts, theories, and empirical evidences of extant studies.
The second and third phases present a new analytical approach in stakeholder analysis terms, linking stakeholder analysis with organizational strategy development. The stakeholder analysis of this dissertation is performed by adopting two different types of the formal qualitative analysis - an event structure analysis and a qualitative comparative Boolean analysis -- examining 48 major global public health-related cases (which consist of 146 events) from 1987 to 2007. The stakeholder analysis examines: the key stakeholders of the pharmaceutical industry; the circumstances/conditions under which the pharmaceutical industry has put measures of stakeholder management into practice; and the types of the measures that have been adopted by the pharmaceutical industry to deal with its stakeholders in conjunction with the ability to gain access to essential, life-saving medicines.
The fourth phase constructs an analogical reasoning model for the pharmaceutical industry in comparison with the food and beverage industry. In the last phase, a specific stakeholder management strategy for the pharmaceutical industry is suggested: i.e., the comprehensive, proactive, multi-stakeholder public-private partnership. This strategic option is developed based on the outcomes of the stakeholder analysis combined with those of the analogical reasoning model.
The new strategic direction for the pharmaceutical industry suggested in this dissertation provides an integrated approach to the industry’s strategic decision making to satisfy the multiple types of stakeholders simultaneously. It is expected that this new organizational strategy for the pharmaceutical industry can be a useful tool to realize a comprehensive win-win situation: i.e., for the pharmaceutical industry in the stakeholder management terms and for its stakeholders in the access to essential, life-saving medicine terms.
The second and third phases present a new analytical approach in stakeholder analysis terms, linking stakeholder analysis with organizational strategy development. The stakeholder analysis of this dissertation is performed by adopting two different types of the formal qualitative analysis - an event structure analysis and a qualitative comparative Boolean analysis -- examining 48 major global public health-related cases (which consist of 146 events) from 1987 to 2007. The stakeholder analysis examines: the key stakeholders of the pharmaceutical industry; the circumstances/conditions under which the pharmaceutical industry has put measures of stakeholder management into practice; and the types of the measures that have been adopted by the pharmaceutical industry to deal with its stakeholders in conjunction with the ability to gain access to essential, life-saving medicines.
The fourth phase constructs an analogical reasoning model for the pharmaceutical industry in comparison with the food and beverage industry. In the last phase, a specific stakeholder management strategy for the pharmaceutical industry is suggested: i.e., the comprehensive, proactive, multi-stakeholder public-private partnership. This strategic option is developed based on the outcomes of the stakeholder analysis combined with those of the analogical reasoning model.
The new strategic direction for the pharmaceutical industry suggested in this dissertation provides an integrated approach to the industry’s strategic decision making to satisfy the multiple types of stakeholders simultaneously. It is expected that this new organizational strategy for the pharmaceutical industry can be a useful tool to realize a comprehensive win-win situation: i.e., for the pharmaceutical industry in the stakeholder management terms and for its stakeholders in the access to essential, life-saving medicine terms.
PhysicalDescription
Form
(authority = gmd)
electronic resource
Extent
xi, 377 p. : ill.
InternetMediaType
application/pdf
InternetMediaType
text/xml
Note
Supplementary File: Figure 1: ETHNO Diagram
Note
Supplementary File: Figure 2-1: ETHNO Diagram
Note
Supplementary File: Figure 2-2: ETHNO Diagram
Note
Supplementary File: Figure 2-3: ETHNO Diagram
Note
Supplementary File: Figure 3: ETHNO Diagram
Note
Supplementary File: Figure 4: ETHNO Diagram
Note
Supplementary File: Figure 5: ETHNO Diagram
Note
Supplementary File: Figure 6: ETHNO Diagram
Note
(type = degree)
Ph.D.
Note
(type = bibliographic history)
Includes bibliographical references (p. 349-376)
Note
(type = statement of responsibility)
by Hyuk Kim
Name
(ID = NAME-1);
(type = personal)
NamePart
(type = family)
Kim
NamePart
(type = given)
Hyuk
NamePart
(type = date)
1968-
Role
RoleTerm
(authority = RULIB);
(type = )
author
DisplayForm
Hyuk Kim
Name
(ID = NAME-2);
(type = personal)
NamePart
(type = family)
Cantwell
NamePart
(type = given)
John
Role
RoleTerm
(authority = RULIB);
(type = )
chair
Affiliation
Advisory Committee
DisplayForm
John Cantwell
Name
(ID = NAME-3);
(type = personal)
NamePart
(type = family)
Langhorne
NamePart
(type = given)
Richard
Role
RoleTerm
(authority = RULIB);
(type = )
internal member
Affiliation
Advisory Committee
DisplayForm
Richard Langhorne
Name
(ID = NAME-4);
(type = personal)
NamePart
(type = family)
Hassan
NamePart
(type = given)
Mahmud
Role
RoleTerm
(authority = RULIB);
(type = )
internal member
Affiliation
Advisory Committee
DisplayForm
Mahmud Hassan
Name
(ID = NAME-5);
(type = personal)
NamePart
(type = family)
Christmann
NamePart
(type = given)
Petra
Role
RoleTerm
(authority = RULIB);
(type = )
internal member
Affiliation
Advisory Committee
DisplayForm
Petra Christmann
Name
(ID = NAME-1);
(type = corporate)
NamePart
Rutgers University
Role
RoleTerm
(authority = RULIB);
(type = )
degree grantor
Name
(ID = NAME-2);
(type = corporate)
NamePart
Graduate School - Newark
Role
RoleTerm
(authority = RULIB);
(type = )
school
OriginInfo
DateCreated
(point = );
(qualifier = exact)
2010
DateOther
(qualifier = exact);
(type = degree)
2010-01
Place
PlaceTerm
(type = code)
xx
Location
PhysicalLocation
(authority = marcorg)
NjNbRU
RelatedItem
(type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
Identifier
(type = RULIB)
ETD
RelatedItem
(type = host)
TitleInfo
Title
Graduate School - Newark Electronic Theses and Dissertations
Identifier
(type = local)
rucore10002600001
Identifier
(type = doi)
doi:10.7282/T3XK8FPQ
Genre
(authority = ExL-Esploro)
ETD doctoral
Back to the top
Rights
RightsDeclaration
(AUTHORITY = GS);
(ID = rulibRdec0006)
The author owns the copyright to this work.
Copyright
Status
Copyright protected
Notice
Note
Availability
Status
Open
Reason
Permission or license
Note
RightsHolder
(ID = PRH-1);
(type = personal)
Name
FamilyName
Kim
GivenName
Hyuk
Role
Copyright Holder
RightsEvent
(AUTHORITY = rulib);
(ID = RE-1)
Type
Permission or license
Label
Place
DateTime
2010-01-11 11:22:26
Detail
AssociatedEntity
(AUTHORITY = rulib);
(ID = AE-1)
Role
Copyright holder
Name
Hyuk Kim
Affiliation
Rutgers University. Graduate School - Newark
AssociatedObject
(AUTHORITY = rulib);
(ID = AO-1)
Type
License
Name
Author Agreement License
Detail
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.
Back to the top
Technical
An error occurred while attempting to load this metadata section
Back to the top
Statistical Profile